Cinderella APP vs CellPoint使用状況と統計
The CINDERELLA Patient APP is part of the EU-funded research project CINDERELLA Project (Grant Agreement number 101057389).
- Visualize the outcome of your operation
- A.I. supported comparison with patients like you
- Detailed background information about breast cancer, the planned operation procedure, and more
- Detailed explanation videos from breast cancer nurses about the procedures within the clinic
The CINDERELLA project intends to test and validate the implementation of an AI-based tool for a safer and evidence-based clinical decision for patients proposed for locoregional treatment, making it easily applied in clinical practice anywhere in the world. A better prediction of aesthetic outcomes of the different breast surgical approaches can improve patient satisfaction and quality of life, reduce anxiety and depression levels, as well as potential revisional surgeries.
To get an account you have to be participating in the CINDERELLA trial and your care team will provide the login details for the app.
Details about the Cinderella Project can be found here https://cinderellaproject.eu/
Disclaimer:
The CINDERELLA - App does not replace direct physician contact! Please contact your care team as soon as you have any questions or difficulties. Always follow your care team's instructions.
- Apple App ストア
- 無料
- ヘルス ＆ フィットネス
ストアランキング
- -
The CellPoint application has been developed for oncology patients enrolled in CellPoint CAR-T therapies at the point-of-care. The CellPoint application can be linked to the CardioWatch 287-2B bracelet. This bracelet and the application are intended for continuous monitoring of vital signs and capturing questionnaires throughout the patient’s treatment with CAR-T therapies.
The CardioWatch 287-2B is a medically certified wireless remote monitoring system intended for continuous collection of vital parameters in home and in healthcare settings. CardioWatch 287 is a CE medical device certified under EU-MDR standards.
Data is transmitted wirelessly from the device via the application to the health cloud where it is stored and made available for further analysis.
About CellPoint
CellPoint, a Galapagos company, is dedicated to developing CAR-T therapies at the point-of-care, making these therapies more affordable and accessible to patients. CellPoint has developed a rapid manufacturing process, powered by its proprietary xCellit real-time monitoring software system, that allows for 1 week vein-to-vein time compared to over one month with current industry manufacturing platforms. A first proprietary CD19 CAR-T investigational therapy is currently in Phase1/2a trials to provide fast clinical validation of the decentralized point-of-care production model. More information at www.cellpoint.bio.
This application is only supported by phones with Bluetooth® 5.0 Low Energy.
For Non European customers, CardioWatch 287 is available as Investigative device to collect body metrics data.
The device is not used for medical diagnostic or treatment. No physical harm risk.
- Apple App ストア
- 無料
- ヘルス ＆ フィットネス
ストアランキング
- -
Cinderella APP VS. 
CellPoint1月 20, 2026